Related references
Note: Only part of the references are listed.Trends in use, pharmacology, and clinical applications of emerging herbal nutraceuticals
Elizabeth M. Williamson et al.
BRITISH JOURNAL OF PHARMACOLOGY (2020)
Growth effects of N-acylethanolamines on gut bacteria reflect altered bacterial abundances in inflammatory bowel disease
Nadine Fornelos et al.
NATURE MICROBIOLOGY (2020)
Members of the endocannabinoid system are distinctly regulated in inflammatory bowel disease and colorectal cancer
Magdalena Grill et al.
SCIENTIFIC REPORTS (2019)
The non-euphoric phytocannabinoid cannabidivarin counteracts intestinal inflammation in mice and cytokine expression in biopsies from UC pediatric patients
E. Pagano et al.
PHARMACOLOGICAL RESEARCH (2019)
The role of n-3 PUFA-derived fatty acid derivatives and their oxygenated metabolites in the modulation of inflammation
Ian de Bus et al.
PROSTAGLANDINS & OTHER LIPID MEDIATORS (2019)
Differential modulation of white adipose tissue endocannabinoid levels by n-3 fatty acids in obese mice and type 2 diabetic patients
Martin Rossmeisl et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS (2018)
The Use of Cannabinoids in Colitis: A Systematic Review and Meta-Analysis
Daniel G. Couch et al.
INFLAMMATORY BOWEL DISEASES (2018)
The current state of the art for biological therapies and new small molecules in inflammatory bowel disease
Sudarshan Paramsothy et al.
MUCOSAL IMMUNOLOGY (2018)
The role of diet in the aetiopathogenesis of inflammatory bowel disease
Hamed Khalili et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2018)
Docosahexaenoic Acid Attenuated Experimental Chronic Colitis in Interleukin 10-Deficient Mice by Enhancing Autophagy Through Inhibition of the mTOR Pathway
Jie Zhao et al.
JOURNAL OF PARENTERAL AND ENTERAL NUTRITION (2017)
Lifelong imbalanced LA/ALA intake impairs emotional and cognitive behavior via changes in brain endocannabinoid system
Erica Zamberletti et al.
JOURNAL OF LIPID RESEARCH (2017)
Cannabinoids as gastrointestinal anti-inflammatory drugs
A. Fabisiak et al.
NEUROGASTROENTEROLOGY AND MOTILITY (2017)
An Examination of Diet for the Maintenance of Remission in Inflammatory Bowel Disease
Natasha Haskey et al.
NUTRIENTS (2017)
Cannabinoids for treating inflammatory bowel diseases: where are we and where do we go?
Carina Hasenoehrl et al.
EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY (2017)
The intestinal barrier: a fundamental role in health and disease
Maaike Vancamelbeke et al.
EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY (2017)
Actions and Mechanisms of Polyunsaturated Fatty Acidson Voltage-Gated Ion Channels
Fredrik Elinder et al.
FRONTIERS IN PHYSIOLOGY (2017)
Actors and Factors in the Resolution of Intestinal Inflammation: Lipid Mediators As a New Approach to Therapy in Inflammatory Bowel Diseases
Federica Ungaro et al.
FRONTIERS IN IMMUNOLOGY (2017)
Cannabimimetic phytochemicals in the diet - an evolutionary link to food selection and metabolic stress adaptation?
Jurg Gertsch
BRITISH JOURNAL OF PHARMACOLOGY (2017)
Development of a Rapid LC-MS/MS Method for the Quantification of Cannabidiol, Cannabidivarin, Δ9-Tetrahydrocannabivarin, and Cannabigerol in Mouse Peripheral Tissues
Fabiana Piscitelli et al.
ANALYTICAL CHEMISTRY (2017)
Fish oil enhances intestinal barrier function and inhibits corticotropin-releasing hormone/corticotropin-releasing hormone receptor 1 signalling pathway in weaned pigs after lipopolysaccharide challenge
Huiling Zhu et al.
BRITISH JOURNAL OF NUTRITION (2016)
Role of Cannabinoids in Gastrointestinal Mucosal Defense and Inflammation
Klara Gyires et al.
CURRENT NEUROPHARMACOLOGY (2016)
A survey of people with inflammatory bowel disease to investigate their views of food and nutritional issues
L. Kinsey et al.
EUROPEAN JOURNAL OF CLINICAL NUTRITION (2016)
FROM PHYTOCANNABINOIDS TO CANNABINOID RECEPTORS AND ENDOCANNABINOIDS: PLEIOTROPIC PHYSIOLOGICAL AND PATHOLOGICAL ROLES THROUGH COMPLEX PHARMACOLOGY
Alessia Ligresti et al.
PHYSIOLOGICAL REVIEWS (2016)
An Orally Active Cannabis Extract with High Content in Cannabidiol attenuates Chemcally-induced Intestinal Inflammation and Hypermotility in the Mouse
Ester Pagano et al.
FRONTIERS IN PHARMACOLOGY (2016)
The Dual Role of Neutrophils in Inflammatory Bowel Diseases
Odile Wera et al.
JOURNAL OF CLINICAL MEDICINE (2016)
DHA protects against experimental colitis in IL-10-deficient mice associated with the modulation of intestinal epithelial barrier function
Jie Zhao et al.
BRITISH JOURNAL OF NUTRITION (2015)
Role of Transient Receptor Potential Channels in Intestinal Inflammation and Visceral Pain: Novel Targets in Inflammatory Bowel Diseases
Marta Zielinska et al.
INFLAMMATORY BOWEL DISEASES (2015)
The global burden of IBD: from 2015 to 2025
Gilaad G. Kaplan
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2015)
Palmitoylethanolamide, a naturally occurring lipid, is an orally effective intestinal anti-inflammatory agent
Francesca Borrelli et al.
BRITISH JOURNAL OF PHARMACOLOGY (2015)
Comparing histological activity indexes in UC
Aude Bressenot et al.
GUT (2015)
Cannabis for Inflammatory Bowel Disease
Timna Naftali et al.
DIGESTIVE DISEASES (2014)
A Review on Chemical-Induced Inflammatory Bowel Disease Models in Rodents
Puneet Kaur Randhawa et al.
KOREAN JOURNAL OF PHYSIOLOGY & PHARMACOLOGY (2014)
Pharmacology and therapeutics of omega-3 polyunsaturated fatty acids in chronic inflammatory disease
Clara M. Yates et al.
PHARMACOLOGY & THERAPEUTICS (2014)
Beneficial effect of the non-psychotropic plant cannabinoid cannabigerol on experimental inflammatory bowel disease
Francesca Borrelli et al.
BIOCHEMICAL PHARMACOLOGY (2013)
Non-THC cannabinoids inhibit prostate carcinoma growth in vitro and in vivo: pro-apoptotic effects and underlying mechanisms
Luciano De Petrocellis et al.
BRITISH JOURNAL OF PHARMACOLOGY (2013)
Effects of increase in fish oil intake on intestinal eicosanoids and inflammation in a mouse model of colitis
Nabil Bosco et al.
LIPIDS IN HEALTH AND DISEASE (2013)
Cannabinoid actions at TRPV channels: effects on TRPV3 and TRPV4 and their potential relevance to gastrointestinal inflammation
L. De Petrocellis et al.
ACTA PHYSIOLOGICA (2012)
Topical and Systemic Cannabidiol Improves Trinitrobenzene Sulfonic Acid Colitis in Mice
Rudolf Schicho et al.
PHARMACOLOGY (2012)
Cannabidiol enhances anandamide signaling and alleviates psychotic symptoms of schizophrenia
F. M. Leweke et al.
TRANSLATIONAL PSYCHIATRY (2012)
Evaluation of the Cyclooxygenase Inhibiting Effects of Six Major Cannabinoids Isolated from Cannabis sativa
Lucia Renee Ruhaak et al.
BIOLOGICAL & PHARMACEUTICAL BULLETIN (2011)
Non-psychoactive cannabinoids modulate the descending pathway of antinociception in anaesthetized rats through several mechanisms of action
Sabatino Maione et al.
BRITISH JOURNAL OF PHARMACOLOGY (2011)
Effects of cannabinoids and cannabinoid-enriched Cannabis extracts on TRP channels and endocannabinoid metabolic enzymes
Luciano De Petrocellis et al.
BRITISH JOURNAL OF PHARMACOLOGY (2011)
Taming THC: potential cannabis synergy and phytocannabinoid-terpenoid entourage effects
Ethan B. Russo
BRITISH JOURNAL OF PHARMACOLOGY (2011)
Maintenance of Remission in Inflammatory Bowel Disease Using Omega-3 Fatty Acids (Fish Oil): A Systematic Review and Meta-analyses
Dan Turner et al.
INFLAMMATORY BOWEL DISEASES (2011)
Oral administration of docosahexaenoic acid attenuates colitis induced by dextran sulfate sodium in mice
Jae Young Cho et al.
MOLECULAR NUTRITION & FOOD RESEARCH (2011)
Effect of dietary krill oil supplementation on the endocannabinoidome of metabolically relevant tissues from high-fat-fed mice
Fabiana Piscitelli et al.
NUTRITION & METABOLISM (2011)
Inhibitory Effect of Standardized Cannabis sativa Extract and Its Ingredient Cannabidiol on Rat and Human Bladder Contractility
Raffaele Capasso et al.
UROLOGY (2011)
The effects of Δ9-tetrahydrocannabinol and cannabidiol alone and in combination on damage, inflammation and in vitro motility disturbances in rat colitis
J. M. Jamontt et al.
BRITISH JOURNAL OF PHARMACOLOGY (2010)
Dietary n-3 polyunsaturated fatty acids and the aetiology of ulcerative colitis: a UK prospective cohort study
Sneha John et al.
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY (2010)
Intragastric administration of a superoxide dismutase-producing recombinant Lactobacillus casei BL23 strain attenuates DSS colitis in mice
Laurie Watterlot et al.
INTERNATIONAL JOURNAL OF FOOD MICROBIOLOGY (2010)
Cannabinoids and the gut: New developments and emerging concepts
Angelo A. Izzo et al.
PHARMACOLOGY & THERAPEUTICS (2010)
Cannabidiol, a safe and non-psychotropic ingredient of the marijuana plant Cannabis sativa, is protective in a murine model of colitis
Francesca Borrelli et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2009)
Endocannabinoids May Mediate the Ability of (n-3) Fatty Acids to Reduce Ectopic Fat and Inflammatory Mediators in Obese Zucker Rats
Barbara Batetta et al.
JOURNAL OF NUTRITION (2009)
Non-psychotropic plant cannabinoids: new therapeutic opportunities from an ancient herb
Angelo A. Izzo et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2009)
Diet in the aetiology of ulcerative colitis: A European prospective cohort study
Andrew R. Hart et al.
DIGESTION (2008)
Antihyperalgesic effect of a Cannabis sativa extract in a rat model of neuropathic pain:: Mechanisms involved
Francesca Comelli et al.
PHYTOTHERAPY RESEARCH (2008)
Transgenic mice rich in endogenous omega-3 fatty acids are protected from colitis
Christian A. Hudert et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Up-regulation of anandamide levels as an endogenous mechanism and a pharmacological strategy to limit colon inflammation
G D'Argenio et al.
FASEB JOURNAL (2006)
Involvement of the cannabimimetic compound, N-palmitoyl-ethanolamine, in inflammatory and neuropathic conditions:: Review of the available pre-clinical data, and first human studies
NA Darmani et al.
NEUROPHARMACOLOGY (2005)
Dietary n-3 polyunsaturated fatty acids reduce disease and colonic proinflammatory cytokines in a mouse model of colitis
CV Whiting et al.
INFLAMMATORY BOWEL DISEASES (2005)
Dietary olive oil supplemented with fish oil, rich in EPA and DHA (n-3) polyunsaturated fatty acids, attenuates colonic inflammation in rats with DSS-induced colitis
D Camuesco et al.
JOURNAL OF NUTRITION (2005)
Clinical and subclinical intestinal inflammation assessed by the mucosal patch technique:: studies of mucosal neutrophil and eosinophil activation in inflammatory bowel diseases and irritable bowel syndrome
G Kristjánsson et al.
GUT (2004)
Review article: oxidative stress as a pathogenic factor in inflammatory bowel disease - radicals or ridiculous?
L Kruidenier et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2002)
Polyunsaturated fatty acids and inflammatory diseases
A Gil
BIOMEDICINE & PHARMACOTHERAPY (2002)
Molecular targets for cannabidiol and its synthetic analogues: effect on vanilloid VR1 receptors and on the cellular uptake and enzymatic hydrolysis of anandamide
T Bisogno et al.
BRITISH JOURNAL OF PHARMACOLOGY (2001)
Share Paper
